Neurostimulation-Guided Anal Intrasphincteric Botulinum Toxin Injection in Children with Hirschsprungʼs Disease - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Journal of Pediatric Gastroenterology and Nutrition Année : 2019

Neurostimulation-Guided Anal Intrasphincteric Botulinum Toxin Injection in Children with Hirschsprungʼs Disease

Résumé

In Hirschsprung disease (HD), despite successful surgical treatment, 50% of children experience long-term functional gastrointestinal problems, particularly chronic functional obstructive symptoms. We report our experience regarding clinical effects of neurostimulation-guided anal intrasphincteric botulinum toxin (BT) injections on postoperative obstructive symptoms attributed to a nonrelaxing anal sphincter complex in HD patients.

Dates et versions

hal-02281641 , version 1 (09-09-2019)

Identifiants

Citer

Claude Louis-Borrione, Alice Faure, Sarah Garnier, Jean-Michel Guys, Thierry Merrot, et al.. Neurostimulation-Guided Anal Intrasphincteric Botulinum Toxin Injection in Children with Hirschsprungʼs Disease. Journal of Pediatric Gastroenterology and Nutrition, 2019, 68 (4), pp.1. ⟨10.1097/MPG.0000000000002204⟩. ⟨hal-02281641⟩
25 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More